PSI
VRTX icon

Pinnacle Summer Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Pinnacle Summer Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$46K Hold
368
– – 0.01% 354
2015
Q3 		$38K Buy
368
+95
+35% +$12.2K 0.01% 529
2015
Q2 		$34K Sell
273
-20
-7% -$2.52K 0.01% 358
2015
Q1 		$35K Hold
293
– – ﹤0.01% 571
2014
Q4 		$32K Buy
293
+108
+58% +$12.2K ﹤0.01% 588
2014
Q3 		$21K Buy
+185
New +$17.6K ﹤0.01% 679

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Pinnacle Summer Investments's VRTX Position: Q4 2015 in Review

Pinnacle Summer Investments held its Vertex Pharmaceuticals (VRTX) position steady in Q4 2015 at 368 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #354.

Pinnacle Summer Investments first reported a position in VRTX in Q3 2014 and has held it in 6 quarters since. 518 funds tracked by Wall St. Rank hold VRTX as of Q4 2015.

  • Pinnacle Summer Investments held 368 shares of Vertex Pharmaceuticals worth $46K as of Q4 2015.
  • Pinnacle Summer Investments left its Vertex Pharmaceuticals share count unchanged in Q4 2015.
  • Vertex Pharmaceuticals made up 0.01% of Pinnacle Summer Investments's portfolio in Q4 2015, its #354 holding.
  • Pinnacle Summer Investments first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 6 quarters since.
  • 518 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.